Publications by authors named "Kenjiro Aogi"

100Publications

Risk Factors for Lymphedema in Breast Cancer Survivors Following Axillary Lymph Node Dissection.

Prog Rehabil Med 2019 23;4:20190021. Epub 2019 Nov 23.

Department of Rehabilitation Medicine, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2490/prm.20190021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365249PMC
November 2019

Risk factors of impairment of shoulder function after axillary dissection for breast cancer.

Support Care Cancer 2020 May 28. Epub 2020 May 28.

Department of Rehabilitation Medicine, National Hospital Organization Shikoku Cancer Center, Ko-160, Minamiumemoto-cho, Matsuyama City, 7910280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05533-7DOI Listing
May 2020

Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.

Support Care Cancer 2020 May 9. Epub 2020 May 9.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami-umemoto-machi, Matsuyama, Ehime, 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05506-wDOI Listing
May 2020

Impact of gender and employment type on job loss among cancer survivors.

Jpn J Clin Oncol 2020 Jul;50(7):766-771

Division of Cancer Survivorship Research, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyaa040DOI Listing
July 2020

PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of and .

Cancer Res 2020 06 25;80(11):2230-2242. Epub 2020 Mar 25.

Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-3095DOI Listing
June 2020

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer.

Breast Cancer Res Treat 2020 Apr 5;180(3):687-694. Epub 2020 Mar 5.

Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05580-yDOI Listing
April 2020

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

N Engl J Med 2020 02 11;382(7):610-621. Epub 2019 Dec 11.

From Memorial Sloan Kettering Cancer Center, New York (S.M.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (C.S., J.C.), and IOB Institute of Oncology, Quiron Group, Barcelona and Madrid (J.C.); Kanagawa Cancer Center, Yokohama (T.Y.), National Cancer Center Hospital (K.T.), the Cancer Institute Hospital of the Japanese Foundation for Cancer Research (Y.I.), and the Advanced Cancer Translational Research Institute, Showa University (J.T.), Tokyo, Aichi Cancer Center Hospital, Nagoya (H.I.), Kindai University Faculty of Medicine, Osaka (J.T.), Shikoku Cancer Center, Matsuyama (K.A.), and the National Hospital Organization Kyushu Cancer Center, Fukuoka (E.T.) - all in Japan; Samsung Medical Center (Y.H.P.), Asan Medical Center, University of Ulsan College of Medicine (S.-B.K.), Yonsei Cancer Center, Yonsei University Health System (J. Sohn), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), Seoul, and the National Cancer Center, Gyeonggi (K.S.L.) - all in South Korea; Institut Gustave Roussy, Université Paris-Sud, Villejuif (F.A.), and Centre Eugène Marquis, Rennes (C.P.) - both in France; the US Oncology Network, Virginia Cancer Specialists, Arlington (N.D.); the University of California, Los Angeles-Jonsson Comprehensive Cancer Center, Los Angeles (S.A.H.); Daiichi Sankyo, Basking Ridge, NJ (C.L., S.C., L.Z., J. Shahidi, A.Y.); and the Dana-Farber Cancer Institute, Boston (I.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1914510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458671PMC
February 2020

Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection.

Breast Cancer 2020 Mar 2;27(2):284-290. Epub 2019 Nov 2.

Department of Rehabilitation Medicine, National Hospital Organization Shikoku Cancer Center, Ko-160, Minamiumemoto-Machi, Matsuyama, Ehime, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-01020-yDOI Listing
March 2020

Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.

Breast Cancer Res Treat 2019 Nov 12;178(2):283-294. Epub 2019 Aug 12.

Department of Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05390-xDOI Listing
November 2019

Job resignation after cancer diagnosis among working survivors in Japan: timing, reasons and change of information needs over time.

Jpn J Clin Oncol 2018 Jan;48(1):43-51

Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx143DOI Listing
January 2018

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.

N Engl J Med 2017 06;376(22):2147-2159

From the National Hospital Organization Osaka National Hospital, Osaka (N.M.), Hiroshima City Hiroshima Citizens Hospital, Hiroshima (S. Ohtani), Kyoto Prefectural University of Medicine (I.Y.), and Graduate School of Medicine, Kyoto University (M.T.), Kyoto, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital (K.K.), and Chuo University (Y.O.), Tokyo, Gunma Prefectural Cancer Center, Ota (Y.Y.), National Hospital Organization Kyushu Cancer Center, Fukuoka (S. Ohno), Hyogo Cancer Center, Akashi (S.T.), National Hospital Organization Shikoku Cancer Center, Matsuyama (K.A.), Aichi Cancer Center Hospital, Nagoya (H.I.), and Tohoku University, Sendai (H.S.) - all in Japan; and Yeungnam University Hospital, Daegu (S.-J.L.), Samsung Medical Center, Sungkyunkwan University School of Medicine (Y.-H.I.), Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine (S.-A.I.), Severance Hospital (B.-W.P.) and Gangnam Severance Hospital (J.J.), Yonsei University College of Medicine, Asan Medical Center, University of Ulsan College of Medicine (S.-B.K.), Korea University Guro Hospital (A.K.), and Korea University Anam Hospital (K.-H.P.), Seoul, and National Cancer Center, Goyang-si (E.-S.L.) - all in South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1612645DOI Listing
June 2017

Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study.

Jpn J Clin Oncol 2016 Dec 8;46(12):1088-1094. Epub 2016 Sep 8.

Division of Medical Oncology, Department of Medicine, Saitama University International Medical Center, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyw127DOI Listing
December 2016

Comprehensive prognostic report of the Japanese Breast Cancer Society registry in 2006.

Breast Cancer 2016 Jan 13;23(1):62-72. Epub 2015 Oct 13.

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-015-0646-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691585PMC
January 2016

Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2005.

Breast Cancer 2016 Jan 13;23(1):50-61. Epub 2015 Oct 13.

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-015-0645-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691584PMC
January 2016

Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004.

Breast Cancer 2016 Jan 7;23(1):39-49. Epub 2015 Oct 7.

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-015-0644-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691586PMC
January 2016

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

Breast Cancer Res Treat 2015 Feb 20;150(1):209-17. Epub 2015 Feb 20.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, 791-0280, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-015-3303-9
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3303-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344554PMC
February 2015

Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancer.

Breast Cancer 2016 Mar 18;23(2):211-5. Epub 2014 Jul 18.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0552-0DOI Listing
March 2016

[II.Late recurrence and resistance 2. Overcoming a trial for acquired resistance against hormone therapy for breast cancer].

Authors:
Kenjiro Aogi

Gan To Kagaku Ryoho 2013 Dec;40(13):2510-3

View Article

Download full-text PDF

Source
December 2013

Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.

Clin Breast Cancer 2013 Dec 8;13(6):465-70. Epub 2013 Oct 8.

Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2013.08.015DOI Listing
December 2013

[Clinical experience with gemcitabine treatment for metastatic breast cancer].

Gan To Kagaku Ryoho 2013 Oct;40(10):1355-9

Dept. of Breast Oncology, National Hospital Organization Shikoku Cancer Center.

View Article

Download full-text PDF

Source
October 2013

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study.

Breast Cancer Res Treat 2013 Sep 13;141(2):269-75. Epub 2013 Sep 13.

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-0037, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2687-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785187PMC
September 2013

Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan.

Cancer Chemother Pharmacol 2013 Jun 28;71(6):1427-33. Epub 2013 Mar 28.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-cho, Matsuyama, Ehime 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2140-yDOI Listing
June 2013

[Genetic counseling and practice of hereditary cancers at Shikoku Cancer Center].

Gan To Kagaku Ryoho 2013 Feb;40(2):139-42

Familial Tumor Counseling Service, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.

View Article

Download full-text PDF

Source
February 2013

[Clinical utility of adjuvant TC regimen].

Authors:
Kenjiro Aogi

Nihon Rinsho 2012 Sep;70 Suppl 7:597-600

Department of Breast Oncology, NHO Shikoku Cancer Center.

View Article

Download full-text PDF

Source
September 2012

Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?

Breast Cancer 2014 Mar 9;21(2):177-82. Epub 2012 May 9.

Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou-160, Minamiumemoto-Machi, Matsuyama, Ehime, 791-0280, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-012-0369-7DOI Listing
March 2014

Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Horm Cancer 2012 Aug 3;3(4):147-59. Epub 2012 Apr 3.

Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12672-012-0111-0DOI Listing
August 2012

Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy.

Breast Cancer 2013 Jul 17;20(3):247-53. Epub 2012 Mar 17.

Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou-160, Minamiumemoto-Machi, Matsuyama, Ehime, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-012-0335-4DOI Listing
July 2013

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.

Breast Cancer 2014 Jan 2;21(1):20-7. Epub 2012 Mar 2.

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-012-0344-3DOI Listing
January 2014

Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer.

Breast Cancer 2013 Jul 15;20(3):218-22. Epub 2012 Feb 15.

Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou-160, Minamiumemoto-Machi, Matsuyama, Ehime, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12282-011-0331
Web Search
http://link.springer.com/10.1007/s12282-011-0331-0
Publisher Site
http://dx.doi.org/10.1007/s12282-011-0331-0DOI Listing
July 2013

[Efficacy and safety of aprepitant in patients with breast cancer].

Gan To Kagaku Ryoho 2011 Aug;38(8):1307-11

Division of Pharmacy, Shikoku Cancer Center, Aichi Cancer Center Research Institute.

View Article

Download full-text PDF

Source
August 2011

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.

Support Care Cancer 2012 Jul 2;20(7):1507-14. Epub 2011 Aug 2.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Ko, Minami-Umemoto, Matsuyama, Ehime 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-011-1239-0DOI Listing
July 2012

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study.

Breast Cancer Res Treat 2011 Oct 31;129(3):829-38. Epub 2011 Jul 31.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1685-xDOI Listing
October 2011

Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.

Breast Cancer Res Treat 2011 Nov 13;130(1):267-72. Epub 2011 May 13.

Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, Matsuyama, 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1561-8DOI Listing
November 2011

Examination of the use of Exemestane in patients with metastatic breast cancer.

Breast Cancer 2011 Jul 25;18(3):189-94. Epub 2011 Mar 25.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Ko, Minamiumemoto-cho, Matsuyama, Ehime, 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-011-0258-5DOI Listing
July 2011

Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.

Oncology 2010 4;79(3-4):273-7. Epub 2011 Mar 4.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322371DOI Listing
May 2011

Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens.

Virchows Arch 2011 Feb 21;458(2):153-8. Epub 2010 Dec 21.

Department of Clinical Laboratory, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-machi, Matsuyama, Ehime, 791-0280, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00428-010-1025
Web Search
http://link.springer.com/10.1007/s00428-010-1025-2
Publisher Site
http://dx.doi.org/10.1007/s00428-010-1025-2DOI Listing
February 2011

A case of small undifferentiated intramucosal gastric cancer with lymph node metastasis.

Gastric Cancer 2010 Nov 3;13(4):264-6. Epub 2010 Dec 3.

Department of Internal Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10120-010-0562-3
Publisher Site
http://dx.doi.org/10.1007/s10120-010-0562-3DOI Listing
November 2010

Metastatic Breast Cancer to the Stomach Resembling Early Gastric Cancer.

Case Rep Oncol 2010 Apr 29;3(2):142-147. Epub 2010 Apr 29.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000313923DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919990PMC
April 2010

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy.

Case Rep Oncol 2010 Apr 29;3(2):137-141. Epub 2010 Apr 29.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000313921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919989PMC
April 2010

The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype.

Cancer Chemother Pharmacol 2011 May 14;67(5):1007-15. Epub 2010 Jul 14.

Department of Breast Oncology, Shikoku Cancer Center, 160 Kou, Minami-umemotocho, Matsuyama 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1390-1DOI Listing
May 2011

[A case of recurrent breast cancer with extensive liver metastasis successfully treated with endocrine therapy].

Gan To Kagaku Ryoho 2009 Dec;36(13):2623-5

Dept. of Breast Oncology, Shikoku Cancer Center.

View Article

Download full-text PDF

Source
December 2009

Efficacy and tolerability of weekly paclitaxel in combination with high-dose toremifene citrate in patients with metastatic breast cancer.

Acta Med Okayama 2009 Aug;63(4):187-94

Department of Surgery, National Hospital Organization, Shikoku Cancer Center, Matsuyama 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/31816DOI Listing
August 2009

Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery.

Jpn J Clin Oncol 2009 Aug 11;39(8):491-6. Epub 2009 Jun 11.

Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, Kou 160, Minami-umemoto-machi, Matsuyama 791-0280, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyp060DOI Listing
August 2009

Feasibility study of docetaxel with cyclophosphamide as adjuvant chemotherapy for Japanese breast cancer patients.

Jpn J Clin Oncol 2009 Aug 1;39(8):478-83. Epub 2009 Jun 1.

Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine, 2-5-1 Shikata, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyp050DOI Listing
August 2009

Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.

Jpn J Clin Oncol 2009 Jan 8;39(1):16-21. Epub 2008 Nov 8.

Department of Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyn120DOI Listing
January 2009